Cerity Partners LLC Purchases 113,070 Shares of STERIS plc $STE

Cerity Partners LLC lifted its position in STERIS plc (NYSE:STE) by 116.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 209,923 shares of the medical equipment provider’s stock after purchasing an additional 113,070 shares during the quarter. Cerity Partners LLC’s holdings in STERIS were worth $53,220,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Nordea Investment Management AB lifted its position in STERIS by 259.0% in the 4th quarter. Nordea Investment Management AB now owns 51,602 shares of the medical equipment provider’s stock worth $13,165,000 after buying an additional 37,228 shares during the last quarter. Dimensional Fund Advisors LP grew its position in STERIS by 9.4% during the third quarter. Dimensional Fund Advisors LP now owns 1,039,351 shares of the medical equipment provider’s stock valued at $257,157,000 after acquiring an additional 89,250 shares during the last quarter. Legal & General Group Plc raised its stake in shares of STERIS by 5.3% during the third quarter. Legal & General Group Plc now owns 693,116 shares of the medical equipment provider’s stock worth $171,505,000 after acquiring an additional 34,981 shares in the last quarter. Elo Mutual Pension Insurance Co bought a new stake in shares of STERIS in the 3rd quarter worth approximately $2,480,000. Finally, Groupama Asset Managment purchased a new stake in shares of STERIS in the 3rd quarter valued at $1,163,000. 94.69% of the stock is currently owned by institutional investors.

Insider Transactions at STERIS

In other STERIS news, Director Richard C. Breeden sold 1,481 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $209.51, for a total value of $310,284.31. Following the transaction, the director owned 38,964 shares in the company, valued at approximately $8,163,347.64. The trade was a 3.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Daniel A. Carestio sold 3,054 shares of the business’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $214.64, for a total transaction of $655,510.56. Following the completion of the transaction, the chief executive officer owned 65,021 shares in the company, valued at $13,956,107.44. The trade was a 4.49% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 5,909 shares of company stock worth $1,257,083 in the last 90 days. Corporate insiders own 1.07% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on STE shares. KeyCorp decreased their target price on shares of STERIS from $291.00 to $269.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 13th. Wall Street Zen lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Weiss Ratings cut STERIS from a “hold (c+)” rating to a “hold (c)” rating in a research note on Wednesday, May 27th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $270.00 price objective on shares of STERIS in a report on Thursday, May 21st. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $278.00.

STERIS Stock Up 1.1%

Shares of STERIS stock opened at $212.42 on Wednesday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.54 and a current ratio of 2.09. STERIS plc has a 52-week low of $195.14 and a 52-week high of $269.44. The company’s 50 day moving average price is $216.83 and its 200-day moving average price is $238.33. The stock has a market capitalization of $20.73 billion, a price-to-earnings ratio of 26.79 and a beta of 0.93.

STERIS (NYSE:STE) last posted its quarterly earnings results on Monday, May 11th. The medical equipment provider reported $2.83 EPS for the quarter, missing analysts’ consensus estimates of $2.86 by ($0.03). The firm had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.59 billion. STERIS had a net margin of 13.18% and a return on equity of 14.15%. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.74 earnings per share. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Equities research analysts forecast that STERIS plc will post 11.18 EPS for the current year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 8th will be given a $0.63 dividend. The ex-dividend date is Monday, June 8th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.2%. STERIS’s payout ratio is presently 31.78%.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.